fda d.i.s.c.o. burst edition: fda approval of ojemda (tovorafenib) for relapsed or refractory ped...
Published 2 months ago • 4.4K plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
3:31
fda d.i.s.c.o. burst edition: fda approval of rezlidhia (olutasidenib) for relapsed or refractor...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of epkinly (epcoritamab-bysp) for relapsed or refracto...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) in combination with azacitidin...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) for patients with relapsed or ...
-
2:31
fda d.i.s.c.o. burst edition: fda approval of tecartus (brexucabtagene autoleucel) for adult pati...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of imjudo (tremelimumab) in combination with imfinzi (...
-
3:00
fda d.i.s.c.o. burst edition: fda approval of fotivda (tivozanib) for adult patients with relapse...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) for adult patients with previo...
-
5:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) in combination with mekinist ...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of carvykti (ciltacabtagene autoleucel) for the treatm...
-
3:30
fda d.i.s.c.o. burst edition: fda approval of sarclisa (isatuximab-irfc) in combination with carf...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) as adjuvant treatment for ...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of abecma (idecabtagene vicleucel) the first fda appro...
-
5:01
fda d.i.s.c.o. burst edition: fda approval of breyanzi (lisocabtagene maraleucel) for second-line...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with lenvim...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of imfinzi (durvalumab) for adult patients with locall...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for patients with metastat...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of lunsumio (mosunetuzumab-axgb) for adult patients wi...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of adcetris (brentuximab vedotin) in combination with ...